Express News | Mind Medicine (MindMed) Inc - “at the Market Offering” Sales Agreement Prospectus Supplement Covering Offering of up to $150 Mln of Common Shares

BreakingsJun 28 19:39

Express News | Mind Medicine (MindMed) Inc Files for Mixed Shelf-SEC Filing

BreakingsJun 28 19:38

MindMed to Be Included in Russell 2000 and Russell 3000 Indexes

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced

BusinesswireJun 28 19:00

Cantor Fitzgerald Reiterates Overweight on Mind Medicine

Cantor Fitzgerald analyst Charles Duncan reiterates Mind Medicine (NASDAQ:MNMD) with a Overweight.

BenzingaJun 22 00:31

MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of

BusinesswireJun 21 19:00

MindMed Announces Constructive End-of-Phase 2 Meeting With U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)

-Aligned on requirements for Phase 3 clinical development of MM120 for the treatment of GAD- -Initiation of Phase 3 program remains on schedule to begin in second half of 2024- Mind Medicine (MindMed) Inc.

BusinesswireJun 20 19:00